Karabayas, M., Brock, J., Fordyce, G., & Basu, N. (2021). P052 Leflunomide and severe COVID-19 outcome: A cautionary observation from the COVID-19 Scottish Registry of Autoimmune Rheumatic Diseases (SCAR-19). Rheumatology (Oxford).
Citación estilo ChicagoKarabayas, Maira, James Brock, Gillian Fordyce, and Neil Basu. "P052 Leflunomide and Severe COVID-19 Outcome: A Cautionary Observation From the COVID-19 Scottish Registry of Autoimmune Rheumatic Diseases (SCAR-19)." Rheumatology (Oxford) 2021.
Cita MLAKarabayas, Maira, James Brock, Gillian Fordyce, and Neil Basu. "P052 Leflunomide and Severe COVID-19 Outcome: A Cautionary Observation From the COVID-19 Scottish Registry of Autoimmune Rheumatic Diseases (SCAR-19)." Rheumatology (Oxford) 2021.